Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis

Patients with nonvalvular atrial fibrillation with stage 4 or 5 chronic kidney disease or undergoing hemodialysis were excluded from phase III randomized trials of nonvitamin K antagonist oral anticoagulants (NOACs). We sought to evaluate the effectiveness and safety of rivaroxaban compared with war...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of medicine 2019-09, Vol.132 (9), p.1078-1083
Hauptverfasser:	Coleman, Craig I., Kreutz, Reinhold, Sood, Nitesh A., Bunz, Thomas J., Eriksson, Daniel, Meinecke, Anna-Katharina, Baker, William L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Adult Aged Aged, 80 and over Anticoagulants - therapeutic use Atrial fibrillation Atrial Fibrillation - drug therapy Atrial Fibrillation - epidemiology Databases, Factual Embolism - epidemiology End-stage kidney disease Factor Xa Inhibitors - therapeutic use Female Hemodialysis Hemorrhage - epidemiology Humans Male Middle Aged Oral anticoagulation Renal Dialysis Renal Insufficiency, Chronic - epidemiology Renal Insufficiency, Chronic - therapy Retrospective Studies Rivaroxaban Rivaroxaban - therapeutic use Stroke - epidemiology United States - epidemiology Warfarin Warfarin - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!